Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Kythera Biopharmaceuticals, Inc. (KYTH)

-NasdaqGS
36.01 Down 0.27(0.74%) 4:00PM EDT
|After Hours : 36.01 0.00 (0.00%) 4:29PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   19,687   12,985  
Cost of Revenue -  1,936  1,188  
Gross Profit -   17,751   11,797  
Operating Expenses
Research Development33,974  43,184  15,766  
Selling General and Administrative16,092  10,505  6,879  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (50,066) (35,938) (10,848)
Income from Continuing Operations
Total Other Income/Expenses Net135  (420)(229)
Earnings Before Interest And Taxes(49,931)(36,358)(11,077)
Interest Expense1,980  441  75  
Income Before Tax(51,911)(36,799)(11,152)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(51,911)(36,799)(11,152)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (51,911) (36,799) (11,152)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (51,911) (36,799) (11,152)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.